Gamma-aminobutyric acid A receptor subunit alpha-6 (GABA\(_A\) alpha-6 (often abbreviated as GABA\(_A\) α6))

The Gamma-aminobutyric acid A receptor subunit alpha-6 is a protein subunit encoded by the GABRA6 gene, forming part of the ligand-gated chloride channel known as the GABA\(_A\) receptor. The α6 subunit is predominantly expressed in the cerebellum, especially in granule cells, where it contributes to tonic inhibitory currents and the precise temporal coordination of sensory-motor processing. GABA\(_A\) receptors assemble as heteropentamers from a pool of 19 possible subunits (6 α, 3 β, 3 γ, δ, ε, θ, π, and 3 ρ), with the α6 subunit often partnering with β and δ subunits in extrasynaptic locations to mediate persistent inhibition. Dysfunction of α6-containing GABA\(_A\) receptors has been implicated in numerous neuropsychiatric and neurological disorders. Drugs interact with these receptors through orthosteric and allosteric mechanisms, and their safety profile depends strongly on subunit selectivity and receptor location[3][1][2][5].

Other names

GABRA6GABA\(_A\) receptor alpha-6 subunitGABA\(_A\) α6

Positive allosteric modulation: Drugs like benzodiazepines and zolpidem enhance the receptor’s response to GABA by binding to allosteric sites[6][3]. Direct activation/inhibition: Some drugs act as agonists or antagonists at the orthosteric site. Channel gating modulation: Certain compounds alter the opening probability and conductance of the chloride channel.